Skip to main content
. Author manuscript; available in PMC: 2008 Oct 15.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2008 May 16;49(9):3999–4007. doi: 10.1167/iovs.07-1468

Figure 3.

Figure 3

CD4+CD25+ Tregs from the eye of recovering m-EAU rats inhibited CD4+CD25 effector T cells. (A) CD4+CD25 responder T cells (4 × 105 cells/well) from the spleens of m-EAU rats (9 days p.i.) were mixed at the indicated ratios with CD4+CD25+ T cells from the eyes or spleens of recovering m-EAU rats (16 days p.i.) and stimulated with R16 (10 μg/mL) presented by irradiated syngeneic spleen APCs (1 × 105/well). T-cell proliferation was measured at 48 hours by [3H]-thymidine uptake and expressed as cpm of triplicate wells. (B) As in (A), but using CD4+CD25+ T cells from the eyes or spleens of recovering r-EAU rats (12 days p.i.). (C) Percentage inhibition of the proliferation of R16-specific CD4+CD25 effector T cells by CD4+CD25+ Tregs derived from the eyes of recovering m-EAU or r-EAU rats or the spleens of recovering m-EAU rats calculated from (A) and (B). Results shown are representative of those from three independent experiments.